|
|
H2013/CTD1295/344/R1
|
Jentadueto 2,5 mg/1000 mg Tablets
|
Linagliptin & Metformin Hydrochloride
|
Boehringer Ingelheim international GmbH
|
Retained
|
Details →
|
|
|
H2013/CTD1293/346/R1
|
Jentadueto 2,5 mg/500 mg Tablets
|
Linagliptin & Metformin
|
Boehringer Ingelheim international GmbH
|
Retained
|
Details →
|
|
|
12639; H98/387
|
VIRAMUNE 200 MG TABLETS
|
NEVIRAPINE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
13162; H98/387
|
VIRAMUNE 50 MG/5 ML SUSPENSION
|
NEVIRAPINE HEMIHYDRATE
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2009/19488/550
|
DUOVENT HFA METERED DOSE INHALER
|
IPRATROPIUM BROMIDE & FENOTEROL HYDROBROMIDE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2008/19521/503
|
PEXOLA 0,125 MG TABLETS
|
PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2008/19569/547
|
PEXOLA 0,25 MG TABLETS
|
PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2008/19570/548
|
PEXOLA 1,0 MG TABLETS
|
PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2024/CTD9189/17041
|
GLYXAMBI 10 MG / 5 MG TABLETS
|
EMPAGLIFLOZIN + LINAGLIPTIN
|
Boehringer Ingelheim international GmbH
|
Withdrawn Voluntarily by MAH
|
Details →
|
|
|
H2024/CTD9190/17044
|
GLYXAMBI 25 MG / 5 MG TABLETS
|
EMPAGLIFLOZIN + LINAGLIPTIN
|
Boehringer Ingelheim international GmbH
|
Withdrawn Voluntarily by MAH
|
Details →
|
|
|
H2014/CTD718/439
|
TRAJENTA 5 MG TABLETS
|
LINAGLIPTIN
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2024/CTD8038/16459
|
PRAXBIND 2.5 G/50 ML SOLUTION FOR INJECTION/INFUSION
|
IDARUCIZUMAB
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2003/189
|
SPIRIVA CAPSULES FOR INHALATION
|
TIOTROPIUM BROMIDE MONOHYDRATE
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2003/189/R1
|
Spiriva Capsules for Inhalation
|
Tiotropium bromide monohydrate
|
Boehringer Ingelheim international GmbH
|
Retained
|
Details →
|
|
|
H2013/CTD519/162/R1
|
Twynsta 40 mg/10 mg Tablets
|
Telmisartan & Amlodipine besylate
|
Boehringer Ingelheim international GmbH
|
Retained
|
Details →
|
|
|
15128
|
METALYSE 8 000 U AND SOLVENT
|
TENECTEPLASE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
15127; H2004/004
|
MOBIC 15 MG/1.5 ML AMPOULES
|
MELOXICAM
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H97/026
|
MOBIC 7,5 MG TABLETS
|
MELOXICAM
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2001/9080/56
|
Actilyse, powder and solvent for solution for…
|
Alteplase
|
Boehringer Ingelheim international GmbH
|
Retained
|
Details →
|
|
|
H2001/9080/56/R1
|
Actilyse, powder and solvent for solution for…
|
Alteplase
|
Boehringer Ingelheim international GmbH
|
Retained
|
Details →
|